2016
DOI: 10.3855/jidc.7542
|View full text |Cite
|
Sign up to set email alerts
|

Antiretroviral therapy does not affect response to chronic hepatitis C therapy in HIV-coinfected patients

Abstract: Introduction: Many patients coinfected with the human immunodeficiency virus (HIV) and hepatitis C virus (HCV) are using highly active antiretroviral therapy (HAART) and HCV therapy with peginterferon (PEG-IFN) and ribavirina (RBV) because the use of direct-acting antivirals is not a reality in some countries. To know the impact of such medications in the sustained virological response (SVR) during HCV treatment is of great importance. Methodology: This was a retrospective cohort study of 215 coinfected HIV/HC… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals

citations
Cited by 0 publications
references
References 44 publications
(57 reference statements)
0
0
0
Order By: Relevance

No citations

Set email alert for when this publication receives citations?